Immuneering
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $58,412,886.
Profit Margin
| 2019 | 1.91M | -8.06M | -419.89% |
|---|---|---|---|
| 2020 | 2.31M | -17.03M | -737.17% |
| 2021 | 2.07M | -33.53M | -1612.33% |
| 2022 | 316.95K | -49.28M | -15548.66% |
| 2023 | 0 | -53.47M |
IMRX Income Statement (2019 โ 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 316.95K | 2.07M | 2.31M | 1.91M |
Cost of revenue | 764.13K | 158.12K | 1.15M | 1.28M | 1.22M |
Gross profit | -764.13K | 158.83K | 926.88K | 1.03M | 696.73K |
Operating exp. | |||||
Research and development | 41.40M | 36.26M | 26.54M | 15.00M | 4.27M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 58.41M | 51.90M | 34.81M | 18.11M | 6.98M |
Operating income | -58.41M | -51.74M | -33.88M | -17.08M | -6.29M |
Other income (expenses), net | 4.94M | 1.23M | 42.83K | 42.65K | -1.41M |
Income before tax | -53.47M | -50.51M | -33.84M | -17.03M | -7.70M |
Income tax expense | 0 | -1.23M | -307.48K | -84.33K | 351.30K |
Net income | -53.47M | -49.28M | -33.53M | -17.03M | -8.06M |
Earnings per share | |||||
Basic EPS | -1.88 | -1.87 | -1.27 | -0.67 | -0.32 |
Diluted EPS | -1.88 | -1.87 | -1.27 | -0.67 | -0.32 |
| Data source | Data source | Data source |